Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
11:24am, Wednesday, 22'nd Jul 2020
Scaling The Peaks(Biotech Stocks Hitting 52-week Highs July 21) * ABIOMED, Inc. (NASDAQ: ABMD) * Assembly Biosciences Inc (NASDAQ: ASMB) * Bio-Rad Laboratories, Inc. (NYSE: BIO) * Beigene Ltd (NAS
Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment
08:03am, Wednesday, 22'nd Jul 2020
Shares in Aurinia Pharma (AUPH) surged 9% in Tuesday’s extended trading after the U.S. Food and Drug Administration (FDA) accepted the filing of its New Drug Application (NDA) for voclosporin, a pot
Aurinia Announces U.S. FDA Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis
Aurinia Pharmaceuticals (TSE:AUP) Is In A Good Position To Deliver On Growth Plans
02:02pm, Saturday, 18'th Jul 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Steven Cohen Homes in on Otonomy by Expanding Stake
05:15pm, Wednesday, 15'th Jul 2020
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Did Hedge Funds Make The Right Call On Aurinia Pharmaceuticals Inc (AUPH) ?
12:15am, Monday, 13'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today
Is Aurinia Pharmaceuticals Stock a Buy?
02:20pm, Tuesday, 09'th Jun 2020
Canadian biopharma Aurinia Pharmaceuticals (NASDAQ: AUPH) is undergoing a transformation. The company is embarking on a rare opportunity to deliver the first U.S. Food and Drug Administration (FDA) a
Aurinia Presents Additional AURORA Pivotal Trial Safety Data at the ERA-EDTA Virtual Congress 2020
10:05am, Tuesday, 09'th Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, announc
Hedge Funds Keep Buying Aurinia Pharmaceuticals Inc (AUPH)
07:00am, Monday, 08'th Jun 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Aurinia Presents Aurora Pivotal Trial Subgroup Analysis At The Eular 2020 E-Congress
11:08am, Friday, 05'th Jun 2020Aurinia Presents AURORA Pivotal Trial Subgroup Analysis at the EULAR 2020 E-Congress
11:05am, Friday, 05'th Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, announc
Biotech Stocks: Buy This, Not That
10:34am, Thursday, 04'th Jun 2020
A crucial aspect of success in investing in biotech stocks is that of timing. Buying a stock too early can mean enduring infinite dilution and clinical trial failures before a company can finally bri
Aurinia Announces Results of Annual General Meeting
10:05am, Wednesday, 03'rd Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX: AUP) ("Aurinia" or the "Company") is pleased to announce that the nine incumbent directors of the Company were elected at the Company’s annual gener
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
08:05pm, Monday, 01'st Jun 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat durin
